direct acting antivirals hcv
HCV's days are numbered: next-generation direct-acting antivirals.
HCV Vaccines in the Era of New Direct-acting Antivirals: Expert.
Nov 9, 2012. The changing face of hepatitis C in the new era of direct-acting antivirals. Soriano V, Labarga P, Fernández-Montero JV, Benito JM, Poveda E.
Antiviral resistance and direct-acting antiviral agents for HCV.
Treating Hepatitis C. Current Standard of Care and Emerging Direct-acting Antiviral Agents. F. Poordad, D. Dieterich. Disclosures. J Viral Hepat. 2012.
Background: DAAs appear very promising for the treatment of co-infected patients with HCV genotype 1. Using DAAs, however, may be limited by important.
Dec 21, 2011. The year 2011 marks the dawn of the new era of direct-acting antivirals for hepatitis C. For the first time since 1998, the U.S. Food and Drug.
Feb 19, 2011. Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use - pdf attached. Download the PDF here. Dig Dis Sci. 2011 Feb.
Hepatitis C: New Direct-acting Antivirals in Development : Treatment.
Who needs direct acting antivirals for hepatitis C virus (HCV.